Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 57.37

+0.9%

Dec 8 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (1804)	10/6/2000 3:54:50 PM
From: scaram(o)uche	of 52153

16th chemokine of the CXC subfamily >> Hoping you get a better class of poster here... << It's difficult to look classy when you're dealing with 16 members in one of two major chemokine families, and the sixth receptor for that family. It's good to see that ligands continue to be discovered for orphan receptors, but I didn't see the shares of TRMS, TELK, PGNX, ARNA, MLNM etc. collapse on the news. Just too early to get classy comments. BTW.... someone actually hit a low-ball bid on TELK at 7 1/8 today. Came all the way back to its IPO price.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next